Are you a Veteran of the United States Armed Forces?

Please complete a short survey about prostate cancer care for Veterans to help us learn what's working well and what needs improvement in the care Veterans receive.

Veterans prostate cancer care survey Complete the Survey

Find a Clinical Trial

Clinical trials are an important option to consider for your prostate cancer treatment. Use our clinical trial finder tool to see if a clinical trial may be right for you.

Medical professional holding a chart in front of a group of people

Clinical trials have helped hundreds of thousands of people who are alive today because new, more effective treatments became available. Learn more about clinical trials and whether clinical trials may be an option for you.

All treatment options, including clinical trials, should be considered and discussed with your healthcare provider. Below are prostate cancer clinical trials conducted by ZERO's Clinical Trial Finder sponsors. In addition, you can search for all clinical trials using ZERO’s Clinical Trial Finder. As a 501(c)(3) tax-exempt organization, ZERO Prostate Cancer does not endorse any specific clinical trials. Listing of clinical trials does not imply endorsement. 

Print out your results to discuss with your treatment team or contact the study coordinators directly.

Prostate Cancer Clinical Trials Conducted by ZERO's Clinical Trial Finder Sponsors

Trial ID#: CA071-1000 | NCT06764485

Description: The rechARge clinical study is enrolling Bristol-Myers Squibb is now enrolling for an investigational treatment for individuals with metastatic Castration-Resistant Prostate Cancer (mCRPC). The clinical study, called rechRge, is evaluating how well an investigational oral study drug (BMS-986365) works compared to standard treatments for mCRPC

Trial ID#: NCT06533644

Description: LEGION-100: Investigating SYNC-T for Metastatic Prostate Cancer This clinical trial is enrolling men with advanced prostate cancer that has spread and no longer responds to hormone therapy. SYNC-T Therapy SV-102 combines a procedure that freezes part of a tumor with an infusion of a multi-target drug directly into the tumor, aiming to activate the immune system to fight cancer throughout the body. The trial is evaluating safety, tolerability, and effectiveness.

Share